£128.26

It has never been this cheap. We have no record of a lower price.

£128 today · cheaper than every other day in the last 3 months

Springer Tamoxifen: Pioneering Medicine in Breast Cancer (Milestones in Drug Therapy)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 69 days · 69 data points (no recent data)

Historical
Generating forecast…
£128.26 £121.85 £124.41 £126.98 £129.54 £132.11 £134.67 01 August 2026 18 August 2026 04 September 2026 21 September 2026 08 October 2026
View at Amazon ↗

Price data last checked 22 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 69 days • 1 price levels

Days at Price
69 days 0 17 35 52 69 £128 Days at Price

Price Analysis

Most common price: £128 (69 days, 100.0%)

Price range: £128 - £128

Price levels: 1 different prices over 69 days

Description

Tamoxifen is a pioneering medicine for the treatment and prevention of breast cancer. It is the first drug targeted therapy in cancer to be successful. Tamoxifen targets the tumor estrogen receptor. The therapy is known to have saved the lives of millions of women over the past 40 years. This monograph, written by V. Craig Jordan - known as the “father of tamoxifen” - and his Tamoxifen Team at the Georgetown University Washington DC, illustrates the journey of this milestone in medicine. It includes a personal interview with V. Craig Jordan about his four decades of discovery in breast cancer research and treatment. V. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a “failed morning after contraceptive” to become the “gold standard” for the treatment of breast cancer. He contributed to every aspect of tamoxifen application in therapeutics and all aspects of tamoxifen’s pharmacology. He discovered the selective estrogen receptor modulators (SERMs) and explored the new biology of estrogen-induced apoptosis.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
08 February 2015
Listed Since
05 February 2015

Barcode

No barcode data available

Similar Products You Might Like

Humana Estrogen Receptor and Breast Cancer Discovery Book
97% match

Humana Estrogen Receptor and Breast Cancer Discovery Book

Humana

£127.28 15 Aug 2026
Tamoxifen: Beyond the Antiestrogen - Medical Reference Book
97% match

Tamoxifen: Beyond the Antiestrogen - Medical Reference Book

Birkhauser

£111.64 09 Oct 2026
Tamoxifen: Beyond the Antiestrogen
97% match

Tamoxifen: Beyond the Antiestrogen

Birkhauser

£33.40 10 Oct 2026
TAMOXIFEN CONCEPTS CANCER: New Paradigms (Cancer Etiology, Diagnosis and Treatments: Pharmacology - Research, Safety Testing and Regulation)
97% match

TAMOXIFEN CONCEPTS CANCER: New Paradigms (Cancer Etiology, Diagnosis and Treatments: Pharmacology - Research, Safety Testing and Regulation)

£98.41 19 Sep 2026
Estrogen Action, Selective Estrogen Receptor Modulators And Women's Health: Progress And Promise
96% match

Estrogen Action, Selective Estrogen Receptor Modulators And Women's Health: Progress And Promise

Imperial College Press

£93.20 08 Oct 2026
Molecular Therapy of Breast Cancer: Classicism Meets Modernity (Cancer Etiology, Diagnosis and Treatments Series)
96% match

Molecular Therapy of Breast Cancer: Classicism Meets Modernity (Cancer Etiology, Diagnosis and Treatments Series)

£53.25 11 Sep 2026
Hormone Therapy in Breast and Prostate Cancer (Cancer Drug Discovery and Development)
96% match

Hormone Therapy in Breast and Prostate Cancer (Cancer Drug Discovery and Development)

Humana

£56.97 24 Sep 2026
Ein Jahrhundert endokrine Therapie des Mammakarzinoms: Von Beatson bis heute
95% match

Ein Jahrhundert endokrine Therapie des Mammakarzinoms: Von Beatson bis heute

Springer

£46.99 23 Sep 2026
Breast Cancer: Prognosis, Treatment, and Prevention
95% match

Breast Cancer: Prognosis, Treatment, and Prevention

CRC Press

£41.99 05 Oct 2026
Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)
95% match

Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)

Humana

£144.99 19 Aug 2026
Resistance to Aromatase Inhibitors in Breast Cancer: 8 (Resistance to Targeted Anti-Cancer Therapeutics, 8)
95% match

Resistance to Aromatase Inhibitors in Breast Cancer: 8 (Resistance to Targeted Anti-Cancer Therapeutics, 8)

Springer

£71.32 26 Sep 2026
Breast Cancer: Prognosis, Treatment, and Prevention
95% match

Breast Cancer: Prognosis, Treatment, and Prevention

CRC Press

£150.00 06 Oct 2026
Breast Cancer Survivorship Care: A Resource for Nurses
95% match

Breast Cancer Survivorship Care: A Resource for Nurses

Jones & Bartlett Learning

£46.00 14 Oct 2026
Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)
95% match

Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)

Springer

£70.04 11 Sep 2026
Biological and Hormonal Therapies of Cancer: 94 (Cancer Treatment and Research, 94)
95% match

Biological and Hormonal Therapies of Cancer: 94 (Cancer Treatment and Research, 94)

Springer

£202.30 30 Oct 2026
Neue Konzepte der Diagnostik und Therapie des Mammakarzinoms: Bericht über die 1. wissenschaftliche Tagung der Deutschen Gesellschaft für Senologie: Vor- und Frühstadien des Mammakarzinoms
95% match

Neue Konzepte der Diagnostik und Therapie des Mammakarzinoms: Bericht über die 1. wissenschaftliche Tagung der Deutschen Gesellschaft für Senologie: Vor- und Frühstadien des Mammakarzinoms

Springer

£43.23 23 Sep 2026
Selective Estrogen Receptor Modulators - Research & Clinical Applications
95% match

Selective Estrogen Receptor Modulators - Research & Clinical Applications

Humana

£82.98 10 Oct 2026
Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)
95% match

Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)

Springer

£162.50 15 Oct 2026
Role of the Transcriptome in Breast Cancer Prevention - Springer
95% match

Role of the Transcriptome in Breast Cancer Prevention - Springer

Springer

£111.90 10 Oct 2026
The History and Mystery of Breast Cancer
95% match

The History and Mystery of Breast Cancer

Cambridge Scholars Publishing

£61.99 10 Oct 2026
Springer Biological and Hormonal Therapies of Cancer - Vol 94
95% match

Springer Biological and Hormonal Therapies of Cancer - Vol 94

Springer

£220.34 15 Aug 2026
Estrogen Receptor and Breast Cancer: Celebrating the 60th Anniversary of the Discovery of ER (Cancer Drug Discovery and Development)
95% match

Estrogen Receptor and Breast Cancer: Celebrating the 60th Anniversary of the Discovery of ER (Cancer Drug Discovery and Development)

Humana

£128.11 21 Aug 2026
Breast Cancer: A Guide to Detection and Multidisciplinary Therapy (Current Clinical Oncology)
95% match

Breast Cancer: A Guide to Detection and Multidisciplinary Therapy (Current Clinical Oncology)

Humana

£84.03 10 Oct 2026
Breast Cancer Facts, Myths, and Controversies: Understanding Current Screenings and Treatments (Public Healthissues and Developments)
95% match

Breast Cancer Facts, Myths, and Controversies: Understanding Current Screenings and Treatments (Public Healthissues and Developments)

Bloomsbury

£45.17 30 Sep 2026